Browse News

Found 71 articles

• 

  BioSpace Movers & Shakers, Feb. 21

  2/21/2020

  Biopharma and life sciences companies strengthen their leadership teams and board with this week's Movers & Shakers.

• Roivant Launches Respivant Sciences to Develop Innovative Therapeutics for Respiratory Diseases

  9/17/2018

  Roivant Sciences today announced the launch of Respivant Sciences, a biopharmaceutical company focused on improving the lives of patients suffering from serious respiratory diseases.

• Alexza Pharma Announces Interim Results From Its Phase 2a Study Of AZ-002 (Staccato alprazolam) In Epilepsy Patients

  12/22/2015

• Alexza Pharmaceuticals, Inc. Announces Management Promotions

  10/2/2015

• Alexza Pharmaceuticals, Inc. Announces Management Promotions

  4/30/2015

• Alexza Pharmaceuticals, Inc. Initiates Phase 2a Study Of AZ-002 (Staccato® alprazolam) In Epilepsy Patients

  1/22/2015

• Alexza Pharmaceuticals, Inc. Amends Autoliv Agreement For Heat Packages Used In ADASUVE

  12/17/2014

• Alexza Pharmaceuticals, Inc. Announces The Promotion Of Edwin S. Kamemoto, Ph.D. To Senior Vice President, Regulatory Affairs

  7/1/2014

• Robert A. Lippe Joins Alexza Pharmaceuticals, Inc. As Executive Vice President, Operations And Chief Operations Officer

  2/25/2014

• Alexza Pharmaceuticals, Inc. Announces Management Promotions

  8/1/2013

• Alexza Pharmaceuticals, Inc.'s Agitation Drug Gets FDA Approval

  1/1/2013

• Alexza Pharmaceuticals, Inc. Announces Management Promotions

  8/2/2012

• FDA Approves Alexza Pharmaceuticals, Inc.'s Soliris for Rare Pediatric Blood Disorder

  9/26/2011

• Darl Moreland Joins Alexza Pharmaceuticals, Inc. as Vice President, Quality

  8/12/2010

• Alexza Pharmaceuticals, Inc. Appoints Joseph L. Turner to Its Board of Directors

  7/23/2010

• Alexza Pharmaceuticals, Inc. Migraine Drug Fails to Meet Goal in Study

  9/14/2009

• Alexza Pharmaceuticals, Inc. Promotes Peter D. Noymer, PhD to Vice President, Product R&D

  3/2/2009

• Alexza Pharmaceuticals, Inc.'s Corporate Presentation to be Webcast at the 11th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference

  2/4/2009

• Alexza Pharmaceuticals, Inc. Cuts Jobs, Has Sufficient Cash Till Q2 2010

  1/30/2009

• Endo Pharmaceuticals and Alexza Pharmaceuticals, Inc. Conclude Research Collaboration

  1/30/2009